白藜芦醇负载银纳米颗粒增强对脓毒症诱导急性肝损伤的减轻作用:调节炎症、氧化应激与SIRT1激活
本研究在盲肠结扎穿刺(CLP)所致多微生物脓毒症大鼠模型中,比较白藜芦醇(RV)单用与白藜芦醇负载银纳米颗粒(AgNPs+RV)对脓毒症诱导急性肝损伤的预防作用,设Sham、CLP、RV、AgNPs+RV四组。AgNPs+RV较CLP组显著降低促炎细胞因子(TNF-α、IL-1β、IL-6)、NF-κB激活、presepsin、PCT、8-OHDG与VEGF水平;RV与AgNPs+RV均升高SIRT1水平,提示SIRT1激活可能介导保护效应。作者结论认为AgNPs+RV通过调节炎症、氧化应激与内皮功能障碍表现出极强的减轻脓毒症肝损伤作用,首次评估AgNPs+RV对脓毒症的作用,认为其是处理脓毒症诱导肝损伤有前景的治疗策略,需进一步研究。
要点
- 在CLP多微生物脓毒症大鼠模型中,AgNPs+RV治疗较CLP组显著降低TNF-α、IL-1β、IL-6水平。
- AgNPs+RV较CLP组显著降低NF-κB激活、presepsin、PCT、8-OHDG与VEGF水平,提示减轻脓毒症诱导肝损伤。
- RV与AgNPs+RV治疗均升高SIRT1水平,提示SIRT1激活可能介导保护效应。
- 作者结论认为AgNPs+RV在减轻脓毒症诱导肝损伤方面表现出极强的增强疗效,可能通过SIRT1激活介导。
- 本研究首次评估AgNPs+RV对脓毒症的作用,作者认为其是有前景的治疗策略,需进一步研究。
适用人群与场景
- 盲肠结扎穿刺(CLP)诱导的多微生物脓毒症大鼠模型,设Sham、CLP、RV、AgNPs+RV四组。
研究设计与关键结果
- 研究类型为大鼠模型实验,比较RV单用与RV负载银纳米颗粒(AgNPs+RV)对脓毒症诱导损伤的预防作用。
- AgNPs+RV治疗较CLP组显著降低促炎细胞因子(TNF-α、IL-1β、IL-6)、NF-κB激活、presepsin、PCT、8-OHDG与VEGF水平。
- RV与AgNPs+RV治疗均升高SIRT1水平,提示SIRT1激活可能介导保护效应。
- 作者结论认为AgNPs+RV通过调节炎症、氧化应激与内皮功能障碍,表现出极强的减轻脓毒症诱导肝损伤的疗效,可能通过SIRT1激活介导。
- 本研究首次评估AgNPs+RV对脓毒症的作用。
证据类型、等级与局限
- 证据类型:大鼠模型实验(CLP诱导多微生物脓毒症)。
- 局限:原文报告需进一步研究(warranting further investigation)。
对床旁实践的改变
- 作者认为AgNPs+RV是处理脓毒症诱导肝损伤有前景的治疗策略,需进一步研究;本研究为首次评估AgNPs+RV对脓毒症的作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis-induced acute liver injury is a life-threatening condition involving inflammation, oxidative stress, and endothelial dysfunction. In the present study, the preventive effects of resveratrol (RV) alone and RV-loaded silver nanoparticles (AgNPs + RV) against sepsis-induced damage were investigated and compared in a rat model of polymicrobial sepsis induced by cecal ligation and puncture (CLP). Rats were divided into four groups: Sham, CLP, RV, and AgNPs + RV. Pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation, presepsin, procalcitonin (PCT), 8-hydroxy-2'-deoxyguanosine (8-OHDG), vascular endothelial growth factor (VEGF), and sirtuin-1 (SIRT1) levels were assessed to determine the treatments' effects. AgNPs + RV treatment significantly reduced pro-inflammatory cytokines, NF-κB activation, presepsin, PCT, 8-OHDG, and VEGF levels compared with the CLP group, indicating attenuation of sepsis-induced liver injury. Both RV and AgNPs + RV treatments increased SIRT1 levels, suggesting a potential role of SIRT1 activation in mediating the protective effects. In conclusion, AgNPs + RV treatment demonstrated extremely enhanced efficacy in alleviating sepsis-induced liver injury by modulating inflammation, oxidative stress, and endothelial dysfunction, potentially mediated through SIRT1 activation. In this study, the effect of AgNPs + RV on sepsis was evaluated for the first time, and these findings highlight AgNPs + RV as a promising therapeutic strategy for managing sepsis-induced liver injury, warranting further investigation.
参考来源
- Üstündağ H, Kalindemirtaş FD, Doğanay S, et al. ENHANCED EFFICACY OF RESVERATROL-LOADED SILVER NANOPARTICLE IN ATTENUATING SEPSIS-INDUCED ACUTE LIVER INJURY: MODULATION OF INFLAMMATION, OXIDATIVE STRESS, AND SIRT1 ACTIVATION. Shock. 2023. PMID: 37695728. doi:10.1097/SHK.0000000000002218
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。